Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne.

Background: Topical retinoids in combination with antimicrobials have been proven to reduce acne lesions faster and to a greater degree than antimicrobial therapy alone .

Aims And Objectives: To compare the efficacy and safety of topical combination of 1% Nadifloxacin [NAD] and 0.025% Tretinoin [Tr] with 1% Clindamycin [CLN] and 0.

Comparative effect of telmisartan vs lisinopril on blood pressure in patients of metabolic syndrome.

Objective: The present study was planned to focus on comparative effects of telmisartan vs lisinopril on blood pressure in patients of metabolic syndrome

Methods: The study was carried out on 62 patients of metabolic syndrome from Dec 2010 to Oct 2012 in OPD of Institute. There were two groups, A and B. Group A- Telmisartan (31 patients) and Group B- Lisinopril (31 patients) receiving Telmisartan 40 mg and lisinopril 5 mg orally once a day respectively for 12 weeks.

Study of prescribing pattern of antimicrobial agents in medicine intensive care unit of a teaching hospital in Central India.

Objectives: Intensive care unit (ICU) is a setting where large numbers of drugs are administered to patients and where the cost of hospitalization and drug treatment are high. The primary objective was to evaluate the current usage of anti-microbial agents in the Medical Intensive Care Unit (MICU) of a teaching hospital in central India.

Methods: The study was a prospective study for a period of six months from May 2010 - December 2010.

Efficacy and safety of livwin (polyherbal formulation) in patients with acute viral hepatitis: A randomized double-blind placebo-controlled clinical trial.

Objectives: The study was planned to evaluate the efficacy and safety of Livwin (polyherbal formulation) in acute viral hepatitis.

Materials And Methods: In this study, there were 29 patients in each group, receiving either Livwin (containing Ashwagandha, Arjuna, Bhumyamalaki, Daruharidra, Guduchi, Kutki and Punarnava) or placebo capsules containing lactose powder (500 mg). Both drugs were given orally two capsules two times a day for eight weeks followed by treatment free period of four weeks.